Forward Citations = 12

Loading Chart...

9 inventors (with patents filed for the assignee):

Alexandros Makriyannis (5 out of 57 patents)

Kiran Vemuri (2 out of 3 patents)

Venkata Kiran Vemuri (1 out of 6 patents)

4. Shrouq I Farah (1 out of 2 patents)

5. Manjunath Lamani (1 out of 1 patent)

6. Nikolaos Avlonitis (1 out of 6 patents)

7. Theodora Calogeropoulou (1 out of 3 patents)

8. Maria Koufaki (1 out of 2 patents)

9. Michael Sotirios Malamas (1 out of 76 patents)

5 patents: Sort by Forward Citations

1. 12054480 - Compounds for treating cannabinoid toxicity and acute cannabinoid overdose (2024-08-06),

2. 11939325 - Process for making biologically active compounds and intermediates thereof (2024-03-26),

3. 10662159 - ABHD6 and dual ABHD6/MGL inhibitors and their uses (2020-05-26),

4. 8293211 - CB1 receptor antagonists and uses thereof (2012-10-23),

5. 8097752 - Antiprotozoal ring-substituted phospholipids (2012-01-17),

Company Overview

Makscientific, LLC is a cutting-edge biotechnology company focused on developing innovative solutions for the healthcare and pharmaceutical industries. With a strong emphasis on research and development, Makscientific is dedicated to advancing scientific knowledge and improving patient outcomes through groundbreaking technologies and therapies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#68 in Burlington, MA

#2,894 in Massachusetts

#51,644 in US

Burlington, MA, United States of America

Makscientific, LLC

Forward Citations = 12

9 inventors:

Alexandros Makriyannis (5 out of 57 patents)

Kiran Vemuri (2 out of 3 patents)

Venkata Kiran Vemuri (1 out of 6 patents)

4. Shrouq I Farah (1 out of 2 patents)

5. Manjunath Lamani (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Makscientific, LLC. Retrieved from https://idiyas.com/company/makscientific

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]